Table 1 Histopathological diagnosis of 716 patients with sacral malignant tumors
From: Epidemiological characteristics of 1385 primary sacral tumors in one institution in China
Primary malignant tumor | No.(percentage) in malignant tumors | No.(percentage) in all patients |
|---|---|---|
Chordoma | 316 (44.1%) | 316 (22.8%) |
Chondrosarcoma | 74 (10.3%) | 74 (5.3%) |
Myeloma | 53 (7.4%) | 53 (3.8%) |
Malignant peripheral nerve sheath tumor | 47 (6.6%) | 47 (3.4%) |
Ewing sarcoma | 47 (6.6%) | 47 (3.4%) |
Osteosarcoma | 40 (5.6%) | 40 (2.9%) |
Lymphoma | 35 (4.9%) | 35 (2.5%) |
Solitary fibrous tumor | 20 (2.8%) | 20 (1.4%) |
Undifferentiated pleomorphic sarcoma | 17 (2.4%) | 17 (1.2%) |
Malignant giant cell tumor | 17 (2.4%) | 17 (1.2%) |
Malignant teratoma | 11 (1.5%) | 11 (0.8%) |
Liposarcoma | 10 (1.4%) | 10 (0.7%) |
Ependymoma | 4 (0.6%) | 4 (0.3%) |
Angiosarcoma | 3 (0.4%) | 3 (0.2%) |
Fibrosarcoma | 3 (0.4%) | 3 (0.2%) |
Hemangioendothelima | 3 (0.4%) | 3 (0.2%) |
Myelocytic sarcoma | 3 (0.4%) | 3 (0.2%) |
Yolk sac tumor | 3 (0.4%) | 3 (0.2%) |
Leiomyosarcoma | 2 (0.3%) | 2 (0.1%) |
Alveolar soft part sarcoma | 2 (0.3%) | 2 (0.1%) |
Leukemia | 2 (0.3%) | 2 (0.1%) |
Epithelioid sarcoma | 1 (0.1%) | 1 (0.07%) |
Granulocyte sarcoma | 1 (0.1%) | 1 (0.07%) |
Myofibroblastic sarcoma | 1 (0.1%) | 1 (0.07%) |
Synovial sarcoma | 1 (0.1%) | 1 (0.07%) |